Literature DB >> 21074900

Pathogenicity of exonic indels in fused in sarcoma in amyotrophic lateral sclerosis.

Nicola J Rutherford1, Nicole A Finch, Mariely DeJesus-Hernandez, Richard J P Crook, Catherine Lomen-Hoerth, Zbigniew K Wszolek, Ryan J Uitti, Neill R Graff-Radford, Rosa Rademakers.   

Abstract

Insertion and deletion variants (indels) within poly glycine tracts of fused in sarcoma (FUS) were initially reported as causative of disease in amyotrophic lateral sclerosis (ALS). Subsequent studies identified similar indels in controls and suggested that these indels may confer susceptibility to ALS. We aimed to elucidate the role of previously published and novel exonic indels in FUS in an extensive cohort of 630 ALS patients and 1063 controls. We detected indels in FUS exons 5, 6, 12, and 14 with similar frequencies in patients (0.95%) and controls (0.75%). Exonic indels in poly glycine tracts were also observed with similar frequencies. The largest indel (p.Gly138_Tyr143del) was observed in 1 control. In 1 patient, a 3 base pair deletion in exon 14 (p.Gly475del) was identified, however in vitro studies did not reveal abnormal localization of p.Gly475del mutant FUS. These findings suggest that not all exonic indels in FUS cause disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074900      PMCID: PMC3130814          DOI: 10.1016/j.neurobiolaging.2010.09.029

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  1 in total

1.  Identification of FUS p.R377W in essential tremor.

Authors:  A Rajput; A H Rajput; M L Rajput; M Encarnacion; C Q Bernales; J P Ross; M J Farrer; C Vilariño-Güell
Journal:  Eur J Neurol       Date:  2013-07-03       Impact factor: 6.089

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.